Compounds for proteasome enzyme inhibition

Details for Australian Patent Application No. 2012203602 (hide)

Owner Proteolix, Inc.

Inventors Smyth, Mark S.; Laidig, Guy J.

Agent Shelston IP

Pub. Number AU-A-2012203602

Parent 2005271232

Filing date 20 June 2012

Wipo publication date 12 July 2012

International Classifications

C07K 5/087 Peptides having up to four amino acids in a fully defined sequence

A61K 38/06 Medicinal preparations containing peptides - Tripeptides

A61K 38/07 Medicinal preparations containing peptides - Tetrapeptides

C07K 5/02 Peptides having up to four amino acids in a fully defined sequence

C07K 5/10 Peptides having up to four amino acids in a fully defined sequence

C07K 5/103 Peptides having up to four amino acids in a fully defined sequence

C07K 5/107 Peptides having up to four amino acids in a fully defined sequence

Event Publications

5 July 2012 Complete Application Filed

12 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203602

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203603-Method and apparatus for the production of crystalline silicon substrates

2012203601-Process for producing rare metal